tm
Seeing Is Believing
tm
Seeing Is Believing
HARP is currently covered by 8 analysts with an average potential upside of $11.19 (147.38%) backed by displayed 33 price targets and 52 ratings.
Analysts average stock forecasts to be materialized ratio is 23.15% with an average time for these price targets to be met of 172.78 days.
Highest price target for HARP is 8, Lowest price target is 1, average price target is 4.5.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Sep-2023. First documented stock forecast 11-Nov-2019.
Currently, out of the existing stock ratings of HARP - 18 which are a Buy (78.26%), 5 which are a Hold (21.74%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
33
$28.92 (708.82%)
6
10 days ago
4/10 (40%)
$9.04 (146.84%)
371
Buy
7.5
$3.42 (83.82%)
4.5
14 days ago
2/5 (40%)
$7.34 (230.97%)
70
Hold
2
$-2.08 (-50.98%)
12
9 months 14 days ago
1/5 (20%)
$8.46 (161.02%)
265
Buy
4
$-0.08 (-1.96%)
13
10 months 13 days ago
1/3 (33.33%)
$7.87 (257.77%)
294
Buy
7
$2.92 (71.57%)
30
1 years 1 months 17 days ago
1/4 (25%)
$12.73 (145.28%)
390
What is HARP (Harpoon Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on HARP (Harpoon Therapeutics) with a proven track record?
Which analyst has the current lower performing score on HARP (Harpoon Therapeutics) with a proven track record?
Which analyst has the most public recommendations on HARP (Harpoon Therapeutics)?
Which analyst is the currently most bullish on HARP (Harpoon Therapeutics)?
Which analyst is the currently most reserved on HARP (Harpoon Therapeutics)?
